Rates of Diabetic Ketoacidosis: International Comparison With 49,859 Pediatric Patients With Type 1 Diabetes From England, Wales, the U.S., Austria, and Germany
The DOI matches its Crossref record; 20 of the 21 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Diabetic ketoacidosis (DKA) in children and adolescents with established type 1 diabetes is a major problem with considerable morbidity, mortality, and associated costs to patients, families, and health care systems. We analyzed data from three multinational type 1 diabetes registries/audits with similarly advanced, yet differing, health care systems with an aim to identify factors associated with DKA admissions. RESEARCH DESIGN AND METHODS: Data from 49,859 individuals <18 years with type 1 diabetes duration ≥1 year from the Prospective Diabetes Follow-up Registry (DPV) initiative (n = 22,397, Austria and Germany), the National Paediatric Diabetes Audit (NPDA; n = 16,314, England and Wales), and the T1D Exchange (T1DX; n = 11,148, U.S.) were included. DKA was defined as ≥1 hospitalization for hyperglycemia with a pH <7.3 during the prior year. Data were analyzed using multivariable logistic regression models. RESULTS: The frequency of DKA was 5.0% in DPV, 6.4% in NPDA, and 7.1% in T1DX, with differences persisting after demographic adjustment (P < 0.0001). In multivariable analyses, higher odds of DKA were found in females (odds ratio [OR] 1.23, 99% CI 1.10–1.37), ethnic minorities (OR 1.27, 99% CI 1.11–1.44), and HbA1c ≥7.5% (≥58 mmol/mol) (OR 2.54, 99% CI 2.09–3.09 for HbA1c from 7.5 to <9% [58 to <75 mmol/mol] and OR 8.74, 99% CI 7.18–10.63 for HbA1c ≥9.0% [≥75 mmol/mol]). CONCLUSIONS: These multinational data demonstrate high rates of DKA in childhood type 1 diabetes across three registries/audits and five nations. Females, ethnic minorities, and HbA1c above target were all associated with an increased risk of DKA. Targeted DKA prevention programs could result in substantial health care cost reduction and reduced patient morbidity and mortality.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inability to recognize SFs can lead to diabetic ketoacidosis (DKA), a high-cost acute complication that may be fatal.”
From Real-Time Detection of Infusion Site Failures in a Closed-Loop Artificial Pancreas (2018) · cites this paper as [18]
In the citing paper
“Although the incidence of DKA is not increased by CSII pump use over multiple daily injections”
From Real-Time Detection of Infusion Site Failures in a Closed-Loop Artificial Pancreas (2018) · cites this paper as [18]
In the citing paper
“This study should be interpreted in relation to international rates of DKA in children with T1D, which are higher than in Sweden. 34 , 35”
In the citing paper
“There is also evidence that insulin pump therapy may reduce DKA risk (182,186) and diabetes complications, particularly retinopathy and peripheral neuropathy in youth, compared with MDI (169).”
From 7. Diabetes Technology: Standards of Care in Diabetes—2025 (2025) · cites this paper as [186]
Citations
Cites
Predictors of Acute Complications in Children With Type 1 Diabetes
Rewers, A. (2002) · JAMA · doi:10.1001/jama.287.19.2511 · Cited by 496 · cited 1×
“These indicators of increased risk for DKA are similar to previous reports (10,11,18,19), and our rates of DKA are within the range in the pediatric diabetes literature of 1–15%per established patient per year (10,11).”
ResultProjections of Type 1 and Type 2 Diabetes Burden in the U.S. Population Aged <20 Years Through 2050
Imperatore, G., Boyle, J. P., Thompson, T. J., Case, D., Dabelea, D., Hamman, R. F., Lawrence, J. M., Liese, A. D., Liu, L. L., Mayer-Davis, E. J., et al. (2012) · Diabetes Care · doi:10.2337/dc12-0669 · Cited by 484
The T1D exchange clinic registry
Beck, R. W., Tamborlane, W. V., Bergenstal, R. M., Miller, K. M., DuBose, S. N., Hall, C. A., & for the T1D Exchange Clinic Network (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1561 · Cited by 456
Self-citationCauses of death in children with insulin dependent diabetes 1990-96
Edge, J. A., Ford-Adams, M. E., & Dunger, D. B. (1999) · Archives of Disease in Childhood · doi:10.1136/adc.81.4.318 · Cited by 384
Diabetic ketoacidosis and hyperglycemic hyperosmolar state
Wolfsdorf, J. I., Allgrove, J., Craig, M. E., Edge, J., Glaser, N., Jain, V., Lee, W. W., Mungai, L. N., Rosenbloom, A. L., Sperling, M. A., et al. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12165 · Cited by 371
Self-citationPredictors of glycemic control and short-term adverse outcomes in youth with type 1 diabetes
Levine, B.-S., Anderson, B. J., Butler, D. A., Antisdel, J. E., Brackett, J., & Laffel, L. M. B. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.116283 · Cited by 279 · cited 1×
“These indicators of increased risk for DKA are similar to previous reports (10,11,18,19), and our rates of DKA are within the range in the pediatric diabetes literature of 1–15%per established patient per year (10,11).”
ResultGerstl, E.-M., Rabl, W., Rosenbauer, J., Gröbe, H., Hofer, S. E., Krause, U., & Holl, R. W. (2008) · European Journal of Pediatrics · doi:10.1007/s00431-007-0586-9 · Cited by 201
Self-citationRecent Trends in Hospitalization for Diabetic Ketoacidosis in Ontario Children
Curtis, J. R., To, T., Muirhead, S., Cummings, E., & Daneman, D. (2002) · Diabetes Care · doi:10.2337/diacare.25.9.1591 · Cited by 160
Hanas, R., Lindgren, F., & Lindblad, B. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2008.00441.x · Cited by 129 · cited 2×
“The odds of DKA in pump users was not increased in any registry, which is a marked difference from some (10) but not all historic data (20).”
Result
Research works printed but not linked: 1
- Maahs, 2014, Insulin pump use in pediatric type 1 diabetes: multinational comparison with 54,768 pediatric patients from the T1D Exchange (US), National Paediatric Diabetes Audit (England and Wales), and the DPV Initiative (Germany and Austria), Pediatr Diabetes, 15, O70
Cited by
State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018
Foster, N. C., Beck, R. W., Miller, K. M., Clements, M. A., Rickels, M. R., DiMeglio, L. A., Maahs, D. M., Tamborlane, W. V., Bergenstal, R., Smith, E., et al. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0384 · Cited by 1,907
Self-citationWolfsdorf, J. I., Glaser, N., Agus, M., Fritsch, M., Hanas, R., Rewers, A., Sperling, M. A., & Codner, E. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12701 · Cited by 710
Dhatariya, K. K., Glaser, N. S., Codner, E., & Umpierrez, G. E. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0165-1 · Cited by 461
Karges, B., Schwandt, A., Heidtmann, B., Kordonouri, O., Binder, E., Schierloh, U., Boettcher, C., Kapellen, T., Rosenbauer, J., & Holl, R. W. (2017) · JAMA · doi:10.1001/jama.2017.13994 · Cited by 452
Self-citationGlaser, N., Fritsch, M., Priyambada, L., Rewers, A., Cherubini, V., Estrada, S., Wolfsdorf, J. I., & Codner, E. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13406 · Cited by 390
Metadata
- Authors
- Maahs, D. M., Hermann, J. M., Holman, N., Foster, N. C., Kapellen, T. M., Allgrove, J., Schatz, D. A., Hofer, S. E., Campbell, F., Steigleder-Schweiger, C., Beck, R. W., Warner, J. T., & Holl, R. W.
- Affiliations
- Barbara Davis Center for Childhood Diabetes, Aurora, CO
- Universität Ulm (DE)
- University of Glasgow (GB)
- Jaeb Center for Health Research (US)
- University Hospital Leipzig (DE)
- National Health Service (GB)
- University of Florida (US)
- Innsbruck Medical University (AT)
- Leeds Teaching Hospitals NHS Trust (GB)
- Department of Pediatrics, University Hospital of Salzburg, Paracelsus Medical University, Salzburg, Austria
- University Hospital of Wales (GB)
- Corresponding author
- Foster, Nicole C.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2015-08-17
- Volume
- 38
- Issue
- 10
- Pages
- 1876-1882
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W1603982962
- Cited by
- 224
- References
- 21
- Citations by year
- 2026: 7 · 2025: 19 · 2024: 15 · 2023: 16 · 2022: 24 · 2021: 33 · 2020: 30 · 2019: 29 · 2018: 18 · 2017: 18 · 2016: 13 · 2015: 2
- FWCI
- 14.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Funders
- Bundesministerium für Bildung und Forschung (FKZ 01GI1106)
- Leona M. and Harry B. Helmsley Charitable Trust
- Healthcare Quality Improvement Partnership
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- diabetic ketoacidosis, type 1 diabetes, pediatric diabetes, risk factors, HbA1c, glycemic control, sex differences, ethnic minorities, cross-national comparison, hospitalization, diabetes registry, health care system, T1D Exchange, United States, Austria, Germany
- MeSH terms
- Adolescent, Austria, Child, Child, Preschool, Diabetes Mellitus, Type 1, England, Female, Germany, Hospitalization, Humans, Hyperglycemia, Infant, Male, Prospective Studies, Registries, United States, Wales, Logistic Models, Diabetic Ketoacidosis, Age of Onset
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Rates of Diabetic Ketoacidosis: International Comparison With 49,859 Pediatric Patients With Type 1 Diabetes From England, Wales, the U.S., Austria, and Germany. https://app.cochat.ai/papers/10.2337/dc15-0780
- The paper
- Maahs, D. M., Hermann, J. M., Holman, N., Foster, N. C., Kapellen, T. M., Allgrove, J., Schatz, D. A., Hofer, S. E., Campbell, F., Steigleder-Schweiger, C., Beck, R. W., Warner, J. T., & Holl, R. W. (2015). Rates of Diabetic Ketoacidosis: International Comparison With 49,859 Pediatric Patients With Type 1 Diabetes From England, Wales, the U.S., Austria, and Germany. Diabetes Care. https://doi.org/10.2337/dc15-0780
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.